Atom Investors LP Brainstorm Cell Therapeutics Inc. Call Options Transaction History
Atom Investors LP
- $758 Million
- Q4 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding BCLI
# of Institutions
6Shares Held
511KCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY386KShares$483,0170.0% of portfolio
-
Raymond James & Associates St Petersburg, FL95.2KShares$118,9410.0% of portfolio
-
S.C. Financial Services, Inc.12.7KShares$15,8570.03% of portfolio
-
Advisor Group Holdings, Inc. Phoenix, AZ10.5KShares$13,1480.0% of portfolio
-
Institutional & Family Asset Management, LLC6KShares$7,5000.0% of portfolio
About BRAINSTORM CELL THERAPEUTICS INC.
- Ticker BCLI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,486,200
- Market Cap $45.6M
- Description
- Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company, through its NurOwn proprietary cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem ...